MMP Industries Ltd
Q2 FY22 Earnings Call Analysis
Non - Ferrous Metals
fundraise: Nocapex: Yesrevenue: Category 3margin: Category 3orderbook: No information
💰fundraise
Any current/future new fundraising through debt or equity?
- The company is currently financing expansions, including the second rolling mill, entirely through internal accruals.
- As of now, there are no plans to raise funds through external borrowings or equity.
- Management mentioned that future expansions and capacity increases will also be funded internally.
- No specific timeline or discussion of new debt or equity fundraising was indicated in the call.
- For detailed capital allocation plans, the management offered to respond to investors via email.
🏗️capex
Any current/future capex/capital investment/strategic investment?
- The company is undertaking a rolling mill installation expected to be commissioned by Q4 of the current financial year or Q1 of the next financial year.
- This new rolling mill will increase peak aluminium rolling capacity to 700 metric tons per month.
- The company targets a topline of about Rs. 240-250 Crores with the new rolling mill capacity starting next financial year.
- Expansion is being financed through internal accruals; as of now, there are no plans for external borrowings.
- Management is open to exploring capital allocation strategies including dividend payout and potential new avenues but prefers to reply on these details via email.
- No explicit mention was made of any "big bang" new or different product category investments beyond capacity expansions in foils and powders.
📊revenue
Future growth expectations in sales/revenue/volumes?
- Foil segment is identified as a major growth driver, especially in value-added products like pharma laminate, blister coating, and printing.
- Capacity expansions: Installation of a second rolling mill expected by Q4 this financial year, enabling peak aluminum rolling capacity of 700 MT/month and potential topline of Rs. 240-250 Crores next year.
- Pharma sector approvals underway with large companies like Ajanta Pharma, Sun Pharma, Alkem, and others; ramp-up expected to accelerate post audits and vendor approval processes.
- Powder segment growth is driven mainly by the AAC construction segment, expected to be the fastest-growing area.
- Q2 expected to see 10-15% volume growth over last year despite seasonality.
- Volumes in foil segment currently at ~45-50% capacity in conversion, with plans to raise utilization and thereby margins.
- Overall, growth driven by increased capacity, approvals, and entering new markets (Bangladesh, Nepal, Nigeria).
📈margin
Future growth expectations in earnings/operating earnings/profits/EPS?
- The company expects strong revenue growth particularly in the aluminium foil segment driven by approvals and orders from major pharma companies, along with growth in value-added segments like printing (Page 7, 14).
- Volume growth in the aluminium powder segment is anticipated at 10-15% in Q2 compared to last year despite monsoon-related slowdowns (Page 7).
- Margins currently impacted by volatile metal prices and inflationary pressures, but management hopes for margin stability with aluminum price stabilization (Pages 5-6, 9).
- EBITDA per ton in the powder segment is around Rs. 30,000 to Rs. 35,000; foil EBITDA per ton not yet stable due to evolving business (Page 17).
- Free cash flow positive status is expected sometime next financial year (Page 15).
- Operating asset turnover improvement to about 5 times is targeted within two years, though 6-7 times is currently challenging (Page 9).
- The ramp-up in foil business and conversion segment capacity utilization increase will drive margin expansion (Pages 13-14).
📋orderbook
Current/ Expected Orderbook/ Pending Orders?
- MMP Industries Limited does not maintain a formal order book as orders arrive regularly based on demand rather than being booked months in advance.
- In the powder segment, Q2 is typically the slowest quarter due to seasonal factors such as the monsoon, which reduces mining and construction activities.
- The company expects a 10% to 15% volume growth in Q2 compared to Q2 of the previous year despite it being traditionally slow.
- Foil segment is anticipated to see strong growth with approvals pending from a major pharma company and increasing orders in value-added printing.
- Overall, the business expects growth in both powder and foil segments, but orders are managed on a rolling basis rather than pre-booked.
